[calendarizeit]
The International Myeloma Society (IMS) is proud to announce webIMarS, a new webinar series co-hosted in partnership with local hematology societies. These 90-minute webinars on Relapsed Refractory Multiple Myeloma will be led by local faculty and are designed for regional audiences. The goal of this series is to share updated knowledge in diagnosis, monitoring, and treatment of Plasma Cell malignancies with a focus on the local practice patterns.
On February 12, 2025 the IMS and Myeloma Australia will co-host a 90-minute complimentary webinar for healthcare professionals who actively treat patients with multiple myeloma in Australia.
The International Myeloma Society (IMS) is proud to announce webIMarS, a new webinar series co-hosted in partnership with local hematology societies. These 90-minute webinars on Relapsed Refractory Multiple Myeloma will be led by local faculty and are designed for regional audiences. The goal of this series is to share updated knowledge in diagnosis, monitoring, and treatment of Plasma Cell malignancies with a focus on the local practice patterns.
On February 19, 2025 the IMS and the Japanese Society of Myeloma will co-host a 90-minute complimentary webinar for healthcare professionals who actively treat patients with multiple myeloma in Australia.
Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.
Join us for a dynamic educational workshop on the diagnosis, treatment, and monitoring of plasma cell malignancies, including current practices and opportunities for improvement. This workshop will include lectures plus roundtable discussions around hot and controversial topics, featuring point-counterpoint conversations between invited speakers and local hematologists based on both challenging questions and clinical cases.
The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects.
The International Myeloma Society Meeting is the defining annual meeting in myeloma with a focus on both the basic, preclinical and the clinical aspects.
More details about this meeting will be shared soon.
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide.
The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.